MarketLens
Sign Up

What Do the JADE101 Phase 1 Interim Results Reveal

3 months ago
SHARE THIS ON:

What Do the JADE101 Phase 1 Interim Results Reveal

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News3 weeks ago

Jade Biosciences: Duration Is The Real Product

Jade Biosciences' JADE101 achieved ~70% IgA reduction in Phase 1 with favorable safety, targeting quarterly dosing for IgAN. Phase 2 JUNIPER interim data in 2027 will be pivotal, potentially improving...
Stock News1 months ago

NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears

NewAmsterdam Pharma outlined its obicetrapib cardiovascular strategy at Investor Day, updating clinical programs and commercial prep ahead of a potential European launch, as the PREVAIL interim readou...
Stock News1 months ago

Altimmune, Inc. (ALT) Discusses Topline Results of RECLAIM Phase II Trial of Pemvidutide in Alcohol Use Disorder Transcript

Altimmune discussed topline results from the RECLAIM Phase II trial of pemvidutide in alcohol use disorder. The transcript covers efficacy and safety data from the study.

Breaking News

View All →

Top Headlines

View More →
Stock News2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News6 hours ago

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today